SUZANNE GAZDA M.D.
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • Lectures/Videos
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact

Neurology
​Trends

New research advances our understanding of PANS and PANDAS.

5/18/2021

0 Comments

 
The pandemic made clearer the role of infections in neuropsychiatric conditions.
As any parent whose child suffers with the debilitating symptoms of a neuropsychiatric disorder can attest to, the search for answers and help is often beyond challenging. But now, with more evidence of the neurological impacts in some cases of COVID-19, we see just how intricately connected are the brain and the immune system. ​
Picture
And this adds even more merit to our understanding of pathophysiological mechanisms involved in PANS (pediatric acute-onset neuropsychiatric syndrome) and PANDAS (pediatric autoimmune neurological disorder associated with streptococcal infection.
 
While the effects of the global pandemic have been overwhelming, as one article notes, “amidst worldwide devastation including the loss of loved ones, financial turmoil, isolation, and tremendous stress, COVID-19 has provided the PANS community with something that years of pleading with the medical community failed to do.”
 
Now, medical journals are replete with multiple studies that show the neurologic and psychiatric symptoms that may occur in the weeks and months after a COVID-19 infection. And even long after the infection clears, formerly healthy people are still experiencing severe related effects on mental health. 
 
Research spotlights interplay between the immune system, infection and effects on the brain.
 
In a recent publication, immunologists from Yale School of Medicine and University of California San Francisco presented groundbreaking findings that show the misdirected autoimmune autoantibodies (proteins produced in response to a pathogen) that can mistakenly target and react with a person's own tissues or organs.
Picture
This striking visual created by the PANDAS Network what occurred within the striatum area of the brains of the studied 27 children diagnosed with PANDAS. The striatum is part of the basal ganglia; in humans, it’s divided into the caudate and the putamen and has long been a target of research in obsessive compulsive disorder (OCD), Tourette’s syndrome, and PANDAS.
 
Cholinergic interneurons (CINs) are one of several different types of interneurons in the striatum. They are critical regulators of brain activity and modify the signaling of other cells nearby. The striatum is involved in voluntary motor control; it has a role in cognition and reward processes, and it is involved in OCD. Researchers found that the autoantibodies discovered in PANDAS irritate and bind to CINS, but not to other neurons, providing “strong evidence for striatal CINs as a critical cellular target that may contribute to pathophysiology in children with rapid-onset OCD symptoms, and perhaps in other conditions.”1
Enter IVIG as potential treatment protocol.
 
In the eleven children in the study who received intravenous immunoglobulin (IVIG) therapy, it  diminished from the CINS.  Symptoms of OCD and neuropsychiatric issues were calmed post-IVIG treatment.   

We know from prior research, infections triggers an immune response and subsequently cause the production of antibodies.
 
In previous writing, we also noted the work of Dr. Dritan Agalliu and his findings that include: 

  • In PANDAS, the body mounts an immune response against the strep by producing antibodies. Some patients, due to an unlucky combination of genetic susceptibility, the specific strain of strep they are infected with, and perhaps other factors, produce antibodies against the strep that also attack the body’s own cells, specifically in the basal ganglia, in the case of PANDAS.
 
  • Repeated exposure to Group A streptococcus (GAS) results in the production of proinflammatory TH17 and TH1 lymphocytes (types of white blood cell, part of the immune system). TH17 cells may travel along the olfactory nerves to the brain. They release proinflammatory cytokines (chemical messengers that help regulate immune response) that cause microglia (mediate immune responses in the central nervous system) to release other inflammatory cytokines. Th17 lymphocytes drive autoimmune reactions. This can be useful in understanding central nervous system disorders and other forms of Autoimmune Encephalitides (like COVID-19).
 
  • Cytokines from microglia and TH17 lymphocytes prompt the breakdown of the blood-brain barrier (BBB), which is made up of endothelial cells. The BBB is supposed to prevent specific molecules in the blood from entering the brain; but, when it breaks down, large molecules like antibodies can more easily get into the brain and cause inflammation.
 
  • Antibodies to the GAS in the blood enter the brain via the weakened BBB. Some of them bind to CINS, subsequently impairing their function.
 
  • Reduced activity in the CINs disrupts the signaling of other nearby cells and thus the normal function of the striatum.
 
  • This disruption then leads to the onset of symptoms.

​With treatment, we can seek to remove both the source of infection AND the pathogenic antibodies. While degree of efficacy can be case dependent, when it works, treatment with IVIG may reduce or eliminate the antibodies that bind to the CINs, allowing them to function properly.
Picture
We know that PANS is triggered by infections other than strep and it is expected that there are overlapping mechanisms. We must remember how unlikely it is for each patient with these disorders to have exactly the same pathophysiological mechanisms, so it’s critical that individualized evaluations and treatment plans are implemented each and every time. 
 
For two decades, families whose children are stricken with symptoms of PANS and PANDAS have gone from one clinician or facility to another in search of help and answers that are often not forthcoming. Perhaps now, in the wake of a disease that has wreaked worldwide havoc but also highlighted the link between infection and brain health, we can at long last achieve more understanding and more relief for the many patients we strive to help every day. 
 
In hope and healing,
Dr. Suzanne Gazda

References:
 
1 Xu J, Liu RJ, Fahey S, et al. Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity. Am J Psychiatry. 2021;178(1):48-64. doi:10.1176/appi.ajp.2020.19070698

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    RSS Feed

    Author

    Dr. Suzanne Gazda, Integrative Neurology

    Archives

    February 2024
    January 2024
    November 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    December 2022
    November 2022
    September 2022
    April 2022
    November 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019

    Categories

    All

SITE MAP

HOME
MEET DR. GAZDA
OUR PRACTICE
INTEGRATIVE MEDICINE
OUR APPROACH
CONDITIONS WE TREAT
TREATMENT PROTOCOLS
PATIENT STORIES
FAQ
POLICIES & RATES
BLOG
SCIENTIFICALLY SPEAKING
MEDICAL RESOURCES
JOURNAL ARTICLES
LINKS
BECOME A PATIENT
CONTACT
NEWS
PRODUCT RECOMMENDATIONS

Location

San Antonio, Texas

Telephone

210-692-1245
Fax
210-692-9311

Email

[email protected]
  • Home
  • Meet Dr. Gazda
    • Our Practice
  • Lectures/Videos
  • BLOGS
    • Blog - Long Covid
    • Blog - NEUROLOGY TRENDS
    • Blog - MS in the NEWS
    • Blog - Scientifically Speaking
    • Blog - Guest Articles
  • Our Approach
  • Conditions we treat
    • Alzheimer’s Disease
    • Amyotrophic Lateral Sclerosis (ALS)
    • Long COVID
    • Multiple Sclerosis (MS)
    • PANS | PANDAS
    • Parkinson’s disease
  • Treatment Protocols
  • Patient Stories
  • FAQ
  • Policies & Rates
  • Helpful LInks
  • Medical Resources
  • Journal Articles
  • Product Recommendations
  • Become a Patient
  • NEWS
  • Contact